A Phase 3 trial of a targeted drug developed by Merck and China’s Kelun-Biotech cut by one-third the risk of death in ...
Bristol Myers Squibb reported that one patient died after receiving its investigational CAR-T therapy in an early autoimmune trial ...
Moderna's CEO Stéphane Bancel on what's next after the recent success in cancer vaccine, and how that impacts the company's ...
New guidance is intended to help girls and women — and their doctors — recognize four distinct phases in heart health.
Kennedy Jr. and other top federal health officials announced a new National Institutes of Health center that would ...
What we don’t know is whether people are disconnecting from one another, gradually, over months of interacting with chatbots, ...
We shouldn't confuse illness and the hardships that come with living,” writes family nurse practitioner Kirsten Balin.
Moderna and Merck are racing to submit their personalized cancer vaccine for FDA approval, expected in 2027, according to Moderna CEO Stéphane Bancel.
AstraZeneca has seen major momentum in oncology in recent years. It got a big showcase at Europe's top cancer conference.
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. AbbVie on Monday said it would buy ...
After 100 years, there's finally an effective cancer vaccine. Now comes the push to get them to work in more tumor types.
A multiple sclerosis treatment from Novartis cut by a third the rates of relapses that people with the condition have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results